Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 16, 2026 12:30 ET | Source: Megger

Doble Engineering and Megger Unite to Shape the Future of Electrical Asset Management

Dover, KENT, April 16, 2026 (GLOBE NEWSWIRE) -- Two of the most respected brands in the electrical industry, Doble Engineering and Megger, have announced their strategic merger under the umbrella of...
April 16, 2026 11:30 ET | Source: Research and Markets

Zinc Methionine Chelates Market Forecast Report 2025-2033 Featuring Alltech, Balchem, Titan Biotech, UNO VETCHEM, Zinpro, Chaitanya Biologicals, Chengdu Chelation Biology, JH, Novus, Priya

Dublin, April 16, 2026 (GLOBE NEWSWIRE) -- The "Zinc Methionine Chelates Market Report by Livestock, Countries and Company Analysis 2025-2033" report has been added to ResearchAndMarkets.com's...
April 16, 2026 11:00 ET | Source: Equity Insider

The Infrastructure Play Hiding in Plain Sight Across Cardiac Care

VANCOUVER, British Columbia, April 16, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary – The American heart care market is undergoing a structural shift that most retail investors...
April 16, 2026 10:30 ET | Source: MarketsandMarkets Research Pvt. Ltd.

Hearing Aids Market Set to Reach $14.42 Billion by 2030 | MarketsandMarkets™

Delray Beach, FL, April 16, 2026 (GLOBE NEWSWIRE) -- The global hearing aids market is entering a pivotal growth phase, driven by demographic shifts, rapid technological advancements, and expanding...
April 16, 2026 10:00 ET | Source: MarketsandMarkets Research Pvt. Ltd.

Mold Release Agents Market worth $3.25 billion by 2030 at CAGR 6.32% says MarketsandMarkets™

Delray Beach, FL, April 16, 2026 (GLOBE NEWSWIRE) -- In terms of value, the Mold Release Agents Market global Mold Release Agents market is projected to grow from USD 2.39 billion in 2025 and to...
April 16, 2026 09:20 ET | Source: MAIA Biotechnology, Inc.

MAIA Biotechnology Activates First U.S. Site for Ongoing International Phase 2 Expansion Trial of Novel Telomere Targeting Treatment Targeting Advanced Non-Small Cell Lung Cancer

Exceptional measures of efficacy observed in THIO-101 Phase 2 trial to date include disease control, response rates, and survival data well above standard of care benchmarks 50,000 advanced NSCLC...
April 16, 2026 09:15 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026

Myriad Genetics will share six abstracts, including two podium presentations, at the American Association for Cancer Research (AACR) Annual Meeting.
April 16, 2026 09:00 ET | Source: AIM ImmunoTech Inc.

AIM ImmunoTech Enters Pivotal Value Inflection Phase with Planned Phase 3 Study of Ampligen® in Pancreatic Cancer, Backed by Positive Clinical Signals, Orphan Drug Status, and Global IP

Company to participate in Live Virtual Investor Closing Bell segment today, April 16th at 4:00 PM ET; Register for the event here OCALA, Fla., April 16, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc....
April 16, 2026 09:00 ET | Source: Cycurion

Cycurion, Inc. (NASDAQ: CYCU) to Host High-Impact Online Investor Event with CEO Kevin Kelly – Spotlighting Breakout Growth in AI-Native Cybersecurity

MCLEAN, Va., April 16, 2026 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ: CYCU) (“Cycurion” or the “Company”), a pioneering AI-driven cybersecurity and government technology solutions provider, today...
April 16, 2026 09:00 ET | Source: ENvue Medical, Inc.

ENvue Issues Stockholder Letter & Provides Corporate Update

TYLER, Texas, April 16, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in the advancement of...